217 related articles for article (PubMed ID: 21506642)
1. Influenza virosomes as a vaccine adjuvant and carrier system.
Moser C; Amacker M; Zurbriggen R
Expert Rev Vaccines; 2011 Apr; 10(4):437-46. PubMed ID: 21506642
[TBL] [Abstract][Full Text] [Related]
2. Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.
Moser C; Amacker M; Kammer AR; Rasi S; Westerfeld N; Zurbriggen R
Expert Rev Vaccines; 2007 Oct; 6(5):711-21. PubMed ID: 17931152
[TBL] [Abstract][Full Text] [Related]
3. The virosome concept for influenza vaccines.
Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
[TBL] [Abstract][Full Text] [Related]
4. The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects.
de Bruijn IA; Nauta J; Gerez L; Palache AM
Vaccine; 2006 Nov; 24(44-46):6629-31. PubMed ID: 16901593
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with inactivated, virosomal influenza vaccine.
de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
[TBL] [Abstract][Full Text] [Related]
6. Influenza virosomes as vaccine adjuvant and carrier system.
Moser C; Müller M; Kaeser MD; Weydemann U; Amacker M
Expert Rev Vaccines; 2013 Jul; 12(7):779-91. PubMed ID: 23885823
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccines: the virosome concept.
Wilschut J
Immunol Lett; 2009 Feb; 122(2):118-21. PubMed ID: 19100779
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
[TBL] [Abstract][Full Text] [Related]
10. Influenza virosomes: a flu jab for malaria?
Cavanagh DR; Remarque EJ; Sauerwein RW; Hermsen CC; Luty AJ
Trends Parasitol; 2008 Sep; 24(9):382-5. PubMed ID: 18684667
[TBL] [Abstract][Full Text] [Related]
11. Virosomal adjuvanted antigen delivery systems.
Moser C; Metcalfe IC; Viret JF
Expert Rev Vaccines; 2003 Apr; 2(2):189-96. PubMed ID: 12899570
[TBL] [Abstract][Full Text] [Related]
12. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
Glück R; Metcalfe IC
Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.
Schumacher R; Amacker M; Neuhaus D; Rosenthal R; Groeper C; Heberer M; Spagnoli GC; Zurbriggen R; Adamina M
Vaccine; 2005 Dec; 23(48-49):5572-82. PubMed ID: 16165256
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine with squalene adjuvant: new preparation. No better than available products.
Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987
[TBL] [Abstract][Full Text] [Related]
16. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
Felnerova D; Viret JF; Glück R; Moser C
Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
[TBL] [Abstract][Full Text] [Related]
17. Peptides delivered by immunostimulating reconstituted influenza virosomes.
Westerfeld N; Zurbriggen R
J Pept Sci; 2005 Nov; 11(11):707-12. PubMed ID: 16059967
[TBL] [Abstract][Full Text] [Related]
18. Influenza virosomes in vaccine development.
Huckriede A; Bungener L; Daemen T; Wilschut J
Methods Enzymol; 2003; 373():74-91. PubMed ID: 14714397
[TBL] [Abstract][Full Text] [Related]
19. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.
Lambkin R; Oxford JS; Bossuyt S; Mann A; Metcalfe IC; Herzog C; Viret JF; Glück R
Vaccine; 2004 Oct; 22(31-32):4390-6. PubMed ID: 15474733
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN.
Mallick AI; Parvizi P; Read LR; Nagy E; Behboudi S; Sharif S
Vaccine; 2011 Feb; 29(8):1657-65. PubMed ID: 21195078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
